NM_177402.5:c.465+21delG
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_177402.5(SYT2):c.465+21delG variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_177402.5 intron
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 7Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessiveInheritance: AR Classification: STRONG Submitted by: PanelApp Australia
- presynaptic congenital myasthenic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_177402.5. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD2 exomes AF: 0.00000412 AC: 1AN: 242710 AF XY: 0.00000763 show subpopulations
GnomAD4 exome AF: 6.97e-7 AC: 1AN: 1435436Hom.: 0 Cov.: 0 AF XY: 0.00000141 AC XY: 1AN XY: 711372 show subpopulations
GnomAD4 genome Cov.: 0
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.